Cancun ... it's like you are inside my head dude. Same spidey senses, and view of things almost word for word, and I have a much more relaxed "peaceful easy feeling" now ... (one of my favorite Eagles tunes btw)

It's not "if" anymore, with this recent regulatory status ... but rather who/when and what exactly ...  imho.

Not fully de-risked, but a heckuva a lot closer, with a clearer and hopefully expedited path coming into focus soon ... with a partner or new owner. Has to happen, and BT status is a mammoth confidence, leverage, and valuation-assistance tool. 

Would not be shocked by an interim partnering deal pending further milestones, ... but hopeful that a motivated BP just cuts a deal and takes apabetalone and/or RVX out completely in 2020 sometime. Can't imagine Don and the BoD cutting a deal that "we" won't like ... at this point.

All pure speculation though, and jmho's.

... to use your mantra ... show me the money ... but equally and actually more importantly, let's get this drug to patients in dire need of help who can benefit, and get this door to a new frontier swung wide open.